arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Vivani Medical, Inc.

VANI
$1.42 ▲ +0.04 (+3.28%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
51 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Vivani Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $115.4M
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -28.2%
FCF / Share $-0.08
Trailing P/E
Price / Book 6.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-6.78M
↓ -7.6%
Operating Margin Operating profit as % of sales
-380.5%
↑ +9.2%
FCF / Share Free cash flow per share
$-0.08
↑ +12.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
4
Cash Quality
63

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters